Detalles de la búsqueda
1.
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye.
Future Oncol
; 20(15): 1031-1045, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38014519
2.
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Int J Clin Oncol
; 29(3): 258-265, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310597
3.
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(9): 989-1001, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37591293
4.
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy.
Int J Cancer
; 152(4): 679-685, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082448
5.
Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study.
Cancer
; 129(1): 118-129, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36308296
6.
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.
Anticancer Drugs
; 34(6): 783-790, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729111
7.
Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events.
Future Oncol
; 19(29): 2003-2012, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449387
8.
Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study.
Support Care Cancer
; 31(3): 194, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856870
9.
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data.
Support Care Cancer
; 31(12): 624, 2023 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819422
10.
Intracerebral de novo arterio-venous malformations as a side effect of bevacizumab.
J Oncol Pharm Pract
; : 10781552231171113, 2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37078175
11.
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Urol Int
; 107(6): 595-601, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996793
12.
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Lancet
; 397(10274): 592-604, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581821
13.
Pazopanib-induced chylothorax in a patient with renal cell carcinoma.
Anticancer Drugs
; 33(1): e555-e557, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387587
14.
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.
Eur J Clin Pharmacol
; 78(12): 1973-1979, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266366
15.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol
; 18(23): 2573-2582, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734870
16.
Response to first-line chemotherapy regimen is associated with efficacy of immune checkpoint blockade therapies in patients with metastatic urothelial carcinoma.
Int J Clin Oncol
; 27(3): 585-591, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762201
17.
Oncologists' attitudes towards prophylaxis of cancer associated venous thromboembolism: A prospective, descriptive study.
J Oncol Pharm Pract
; 28(7): 1560-1567, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559022
18.
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy.
J Oncol Pharm Pract
; 28(4): 785-793, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878976
19.
Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data.
Int J Cancer
; 148(10): 2407-2415, 2021 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33284987
20.
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.
Cancer Invest
; 39(6-7): 473-481, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014777